CRDL Latest Press Releases

-- September 23, 2026 --

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx 's Efficacy PRNewswire 6:00 AM

-- September 16, 2026 --

Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds PRNewswire 7:27 AM

-- September 10, 2026 --

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission PRNewswire 5:00 PM

-- September 9, 2026 --

Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference PRNewswire 7:27 AM

-- August 5, 2026 --

Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference PRNewswire 7:27 AM

-- July 14, 2026 --

Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association PRNewswire 7:27 AM

-- July 9, 2026 --

Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit PRNewswire 7:27 AM

-- June 25, 2026 --

Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders PRNewswire 7:27 AM

-- June 23, 2026 --

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT PRNewswire 7:27 AM

Market Data Delayed 15 Minutes